Walleye Trading
AERI

Walleye Trading’s Aerie Pharmaceuticals AERI Stock Holding History

Walleye Trading’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,894
Closed -$119K – 5736
2022
Q2 		$119K Sell
15,894
-3,223
-17% -$22.7K ﹤0.01% 4050
2022
Q1 		$174K Buy
19,117
+3,507
+22% +$27K ﹤0.01% 3908
2021
Q4 		$110K Sell
15,610
-18,412
-54% -$193K ﹤0.01% 4319
2021
Q3 		$388K Buy
+34,022
New +$497K ﹤0.01% 3186
2019
Q3 		– Sell
-10,117
Closed -$232K – 4560
2019
Q2 		$299K Buy
+10,117
New +$390K ﹤0.01% 2615
2018
Q4 		– Sell
-3,615
Closed -$223K – 5528
2018
Q3 		$223K Sell
3,615
-3,598
-50% -$231K ﹤0.01% 3677
2018
Q2 		$487K Buy
7,213
+7,171
+17,074% +$401K ﹤0.01% 2876
2018
Q1 		$2K Sell
42
-14
-25% -$783 ﹤0.01% 4414
2017
Q4 		$3 Buy
+56
New +$3.4K ﹤0.01% 4277
2016
Q1 		– Sell
-1,100
Closed -$27K – 5984
2015
Q4 		$27K Buy
+1,100
New +$25.7K ﹤0.01% 4261
2015
Q3 		– Sell
-500
Closed -$9K – 5657
2015
Q2 		$9K Buy
+500
New +$9.17K ﹤0.01% 4345

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's AERI Position: Q3 2022 in Review

Walleye Trading sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 15,894 shares — an estimated $119K sold.

Walleye Trading first reported a position in AERI in Q2 2015 and held it in 11 quarters. The position peaked at $487K in Q2 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Walleye Trading reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 15,894 Aerie Pharmaceuticals shares in Q3 2022, an estimated $119K.
  • Walleye Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Walleye Trading's Aerie Pharmaceuticals position peaked at $487K in Q2 2018.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.